Osteoporosis News


Generic Versions of Fosamax Approved

-- Scott Roberts

,
HealthDay
Posted: 2008-02-06 14:08:26
WEDNESDAY, Feb. 6 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic equivalents of Fosamax (alendronate sodium), Merck & Co.'s osteoporosis drug.

In a statement, the Israeli firm Teva Pharmaceutical Industries Ltd. said the FDA had approved its new drug application to market the medication in doses of 5 milligrams, 10 milligrams, 35 milligrams, 40 milligrams, and 70 milligrams. Shipment will begin immediately.

The brand-name drug had annual U.S. sales of about $1.9 billion for the period ended Sept. 30, Teva said.

New Jersey-based Barr Pharmaceuticals Inc. also announced that it had received FDA approval to produce a 70-milligram dose of generic Fosamax.

More information

The FDA has more information about this medication.

HealthDay Logo
---
Copyright © 2008 ScoutNews, LLC. All rights reserved.
02/06/2008 12:24 EST

Tools and Resources

  1. Activity Calorie Calculator
  2. Osteoarthritis Health Tools
  3. Osteoporosis Health Tools
  4. Stress Level Calculator
  5. Check Osteoarthritis Symptoms
  6. Resiliency Quiz
  7. More Tools & Resources

    Currently experiencing technical difficulties. Please refresh page or try again later.

    Your Best Body: Delivered

    woman on computer

    Exclusive tips to eat right, stay fit and live well: Keep up with the latest diet and health trends with AOL Body's weekly newsletter.

      Boost Your Metabolism

      running shoes

      Check out these easy ways to rev your metabolism and burn fat in no time.